Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany

DSpace Repository

Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany

Author: Molnar, Daniel; Anastassopoulou, Anastassia; Nautrup, Barbara Poulsen; Schmidt-Ott, Ruprecht; Eichner, Martin; Schwehm, Markus; Dos Santos, Gael; Ultsch, Bernhard; Bekkat-Berkani, Rafik; von Krempelhuber, Alfred; Van Vlaenderen, Ilse; Van Bellinghen, Laure-Anne
Tübinger Autor(en):
Eichner, Martin
Published in: Human Vaccines & Immunotherapeutics (2022), Bd. 18, H. 5
Verlagsangabe: Taylor & Francis Inc
Language: English
Full text: http://dx.doi.org/10.1080/21645515.2022.2058304
ISSN: 2164-5515
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)